Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 4

Post Discharge Short Term Mortality in Hospitalized Patients with Community-Acquired Pneumonia

Pages
417–421
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our findings may help to understand the relation- ship between CAP and mortality, and designing optimal management of comorbidities in this population after discharge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Community-acquired pneumonia (CAP) is one of the most important causes of morbidity and mortality in developed countries, especially in the elderly and adults.
📊
Key Findings & Data:In this study, we aimed to determine the short-term (1 month) mortality rate for CAP after hospitalization and to find the risk factors associated with mortality.
💡
Conclusion & Impact:Our findings may help to understand the relation- ship between CAP and mortality, and designing optimal management of comorbidities in this population after discharge.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Community-acquired pneumonia (CAP) is one of the most important causes of morbidity and mortality in developed countries, especially in the elderly and adults. Thus, the relationship between CAP and short and long-term mortality in patients is critical. A better understanding of CAP related mortality factors can enable us to make inferences for patient care. In this study, we aimed to determine the short-term (1 month) mortality rate for CAP after hospitalization and to find the risk factors associated with mortality. Methods: Hospitalized patients with CAP were classified into two groups as follows: patients who died within 1-month after hospital discharge and patients who survived in the same period. All patients’ data recorded in a computer-assisted protocol. Data were collected on demographic characteristics, comorbidities, causative organisms, laboratory findings, and survival situations. Results: The findings showed that 489 non-immunosuppressed adults with CAP were hospitalized. 11.4% patients died 1-month after the hospitalization. The frequency of male sex and current smokers were similar between the groups. How- ever, patients who died in 1-month after hospital discharge were older. Regarding comorbidities, patients who died within 1-month after hospital discharge more often had chronic renal disease; other comorbidities were more seen in alive patients. Patients who died within 1-month after hospital discharge more often had higher WBC, Neutrophil, Procalcitonin, BUN, AST, PaCO2 value, and lower lymphocyte, Hct, Hb, protein, albumin value than who survived. Length of hospital stay was longer in survived patients than died patients. Discussion and Conclusion: The findings obtained in this study suggest that mortality of in-patients with CAP is remarkably high. Although we could not show any significant independent risk factor for mortality, we can say that some laboratory parameters and some comorbid conditions may affect the mortality rate. Our findings may help to understand the relation- ship between CAP and mortality, and designing optimal management of comorbidities in this population after discharge.

🔖

Cite This Article

ÇINARKA, H., YURT, S., TANRIVERDİ, E., UĞUR, E., TURAN, D., YILDIRIM, B., CORTUK, M., ÇETİNKAYA, E. (2020). Post Discharge Short Term Mortality in Hospitalized Patients with Community-Acquired Pneumonia. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 4, 417–421. https://ajindex.com/articles/161610

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for com- munity-acquired pneumonia in adults in Europe: a literature review. Thorax 2013;68:1057–65
  2. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al; CDC EPIC Study Team. Community-Acquired Pneumo- nia Requiring Hospitalization among U.S. Adults. N Engl J Med 2015;373:415–27
  3. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012;67:71–9
  4. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, et al. New perspectives on community-acquired pneumo- nia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009;64:1062–9
  5. Mortensen EM, Metersky ML. Long-term mortality after pneu- monia. Semin Respir Crit Care Med 2012;33:319–24
  6. Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long- term morbidity and mortality after hospitalization with com- munity-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 2008;87:329–34
  7. Ewig S, Torres A. Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mor- tality. Eur Respir J 2011;38:253–60
  8. T.C. Sağlık Bakanlığı, Refik Saydam Hıfzıssıhha Merkezi Başkan- lığı Hıfzıssıhha Mektebi Müdürlüğü, Başkent Üniversitesi Ulusal Hastalık Yükü ve Maliyeti Etkinlik Projesi, 2004 (www. toraks.org.tr)
  9. Sever F, Kömüs N, Esen N, Gündüz AT, MA Öktem, Çımrın AH. Etiology and Epidemiology of Community-Acquired Pneumo- nia in Turkey. Turk Thorac J 2013;14:5–10
  10. Adamuz J, Viasus D, Jiménez-Martínez E, Isla P, Garcia-Vidal C, Dorca J, et al. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-ac- quired pneumonia. J Infect 2014;68:534–41
  11. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with commu- nity-acquired pneumonia. Clin Infect Dis 2003;37:1617–24
  12. Kolditz M, Tesch F, Mocke L, Höffken G, Ewig S, Schmitt J. Bur- den and risk factors of ambulatory or hospitalized CAP: A pop- ulation based cohort study. Respir Med 2016;121:32–8
  13. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004;169:910–4
  14. Bruns AH, Oosterheert JJ, Cucciolillo MC, El Moussaoui R, Groenwold RH, Prins JM, et al. Cause-specific long-term mor- t